| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.61B | +12.7% |
| Cost of Revenue | $271.0M | +9.7% |
| Gross Profit | $1.34B | +13.3% |
| R&D Expense | $385.2M | +1.2% |
| SG&A Expense | $214.3M | -5.2% |
| Operating Income | $56.8M | +134.9% |
| Pre-tax Income | $100.6M | +228.8% |
| Income Tax | -$181.7M | -4024.0% |
| Net Income | $282.3M | +483.1% |
| EPS (Basic) | $0.52 | +500.0% |
| EPS (Diluted) | $0.52 | +500.0% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $871.2M | -0.9% |
| Short-term Investments | $601.3M | -19.9% |
| Accounts Receivable | $488.3M | +8.2% |
| Current Assets | $2.24B | -4.0% |
| Total Assets | $3.18B | +11.0% |
| Current Liabilities | $905.4M | +13.3% |
| Total Liabilities | $1.10B | +7.6% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $371.2M | +15.8% |
| Capital Expenditures | $19.0M | +27.6% |
| Investing Cash Flow | -$22.5M | +50.6% |
| Financing Cash Flow | -$372.4M | +17.3% |
| Free Cash Flow | $352.2M | +15.2% |
| $2.08B |
| +12.8% |